Gene Biotherapeutics, Inc. CRXM

Full chart Compare
Set alert

Price alert · CRXM

All alert types
0.00 0.00 (+0.00%)

At closeOct 14, 2024, 4:00 PM EDT

0.000001 Day range 0.0001

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $40.04KGross Profit → Expenses: $40.04KRevenue → Cost of Revenue: $69.16KExpenses → Selling, General & Admin: $4.91MExpenses → Research & Development: $2.04MExpenses → Interest Expense: $771Expenses → Other Expenses: $2.01MNet Loss → Expenses: $8.91MGross Profit$40.04KNet Loss$8.91MCost of Revenue$69.16KExpenses$8.95MSelling, General & Admin$4.91MResearch & Development$2.04MInterest Expense$771Other Expenses$2.01MRevenue$109.20K

Latest period ending Dec 31, 2020 · select a line to chart its full history

CRXM annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
-1.26M-837.00K-513.23K-2.08M-2.84M
-517.90K866.67K-434.88K-1.89M-2.92M
-0.020.05-0.03-0.13-0.28
CRXM annual balance sheet
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
386.03K40082.11K48.99K930.40K
566.98K35.44K161.90K209.77K1.11M
5.14M4.89M5.79M5.37M4.40M
739.57K395.96K240.75K211.50K0
-3.88M-4.29M-5.16M-4.80M-3.14M
CRXM annual cash flow
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
-1.13M-137.16K-451.50K-1.06M-2.02M
-3.43K0650.00K0-171.73K
1.52M55.45K-165.37K180.98K3.10M
-3.43K0650.00K0-171.73K
385.63K-81.72K33.13K-881.41K908.85K